| Ralph Ortiz, DO, MPH | |
|
2127 Dryden Rd, Freeville, NY 13068-9611 | |
| (607) 844-9979 | |
| (607) 844-9066 |
| Full Name | Ralph Ortiz |
|---|---|
| Gender | Male |
| Speciality | Interventional Pain Management |
| Experience | 26 Years |
| Location | 2127 Dryden Rd, Freeville, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720171879 | NPI | - | NPPES |
| 02365795 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0000X | Pain Medicine - Pain Medicine | 225765 (New York) | Primary |
| Entity Name | Medical Pain Consultant, Osteopathy Of Tompkins County, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225106313 PECOS PAC ID: 5698872877 Enrollment ID: O20070523000218 |
News Archive
Study findings challenge the belief that preoperative chemotherapy is superior to postoperative chemotherapy for patients with clinical stage III non-small-cell lung cancer.
A new, simple, and inexpensive method that uses ultraviolet light to control particle motion and assembly within liquids could improve drug delivery, chemical sensors, and fluid pumps.
Although there is "no easy fix" for HIV/AIDS in the U.S., "refocusing our sights on improved outcomes and developing a comprehensive strategic plan to achieve them" would be a good start, Chris Collins, author of a new Open Society Institute report on HIV/AIDS in the U.S., writes in a Chicago Defender opinion piece.
Cardioxyl Pharmaceuticals, Inc. announced today that it is presenting two abstracts from studies of its lead clinical candidate, CXL-1020, at the American College of Cardiology's 60th Annual Scientific Session & Expo in New Orleans, Louisiana.
› Verified 2 days ago
| Entity Name | Neurosciences Healthcare Medicine Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497308548 PECOS PAC ID: 5799012993 Enrollment ID: O20190812000709 |
News Archive
Study findings challenge the belief that preoperative chemotherapy is superior to postoperative chemotherapy for patients with clinical stage III non-small-cell lung cancer.
A new, simple, and inexpensive method that uses ultraviolet light to control particle motion and assembly within liquids could improve drug delivery, chemical sensors, and fluid pumps.
Although there is "no easy fix" for HIV/AIDS in the U.S., "refocusing our sights on improved outcomes and developing a comprehensive strategic plan to achieve them" would be a good start, Chris Collins, author of a new Open Society Institute report on HIV/AIDS in the U.S., writes in a Chicago Defender opinion piece.
Cardioxyl Pharmaceuticals, Inc. announced today that it is presenting two abstracts from studies of its lead clinical candidate, CXL-1020, at the American College of Cardiology's 60th Annual Scientific Session & Expo in New Orleans, Louisiana.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ralph Ortiz, DO, MPH Po Box 640, Dryden, NY 13053-0640 Ph: (607) 844-9979 | Ralph Ortiz, DO, MPH 2127 Dryden Rd, Freeville, NY 13068-9611 Ph: (607) 844-9979 |
News Archive
Study findings challenge the belief that preoperative chemotherapy is superior to postoperative chemotherapy for patients with clinical stage III non-small-cell lung cancer.
A new, simple, and inexpensive method that uses ultraviolet light to control particle motion and assembly within liquids could improve drug delivery, chemical sensors, and fluid pumps.
Although there is "no easy fix" for HIV/AIDS in the U.S., "refocusing our sights on improved outcomes and developing a comprehensive strategic plan to achieve them" would be a good start, Chris Collins, author of a new Open Society Institute report on HIV/AIDS in the U.S., writes in a Chicago Defender opinion piece.
Cardioxyl Pharmaceuticals, Inc. announced today that it is presenting two abstracts from studies of its lead clinical candidate, CXL-1020, at the American College of Cardiology's 60th Annual Scientific Session & Expo in New Orleans, Louisiana.
› Verified 2 days ago